Chip-S1 Basic Research Kits, Compound Distribution Kits, and MPS Consumables
Closed Special Notice Posted
- Solicitation number
- FDA-CDER-OTS-26-RFI-A430
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance
- Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The FDA's Center for Drug Evaluation and Research issued a Request for Information on May 29, 2026, to identify qualified vendors capable of supplying Chip-S1 Basic Research Kits, Compound Distribution Kits, and Microphysiological Systems (MPS) consumables, with responses due by June 12, 2026, at 10:00 AM ET. This is market research only; the FDA explicitly disclaims any obligation to issue a solicitation or award a contract based on responses.
The Division of Applied Regulatory Science is evaluating MPS utility in assessing bronchopulmonary disposition of anti-infective drugs and drug transfer into human milk using blood-milk barrier models. The FDA seeks information on availability, pricing, and delivery capabilities for seventeen items: one hardware unit (AVA Emulation System AVA-ES1), two additional hardware components (Orb Hub Module 1 and Zoe Culture Module 2), and fourteen consumable products including basic research chip kits, organ-on-chip co-culture kits, imaging adapter kits, and activation reagents. All MPS chips must be compatible with Emulate's Zoe Culture Module; kits must include Chip-S1 Stretchable Chips with Pod Portable Modules, 8 Steriflip filters, and ER-1/ER-2 activation reagents, with all consumables sterilized and functionally tested before release.
Responses must include company information (UEI, CAGE code, business size, socioeconomic status), capability statements detailing manufacturing or distribution experience, quality certifications (ISO 13485, ISO 9001), product datasheets, rough order of magnitude pricing with volume discounts, standard lead times, and five-year delivery coordination capabilities. Submit responses not exceeding 10 pages in PDF or Word format to Cynthia.Martin@fda.hhs.gov, referencing RFI number FDA-CDER-OTS-26-RFI-A430 in the subject line.
Notice text
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Translational Sciences (OTS), Office of Clinical Pharmacology (OCP), Division of Applied Regulatory Science (DARS), is issuing this Request for Information (RFI) for market research purposes to identify qualified vendors capable of supplying Chip-S1 Basic Research Kits, Compound Distribution Kits, and other Microphysiological Systems (MPS) consumables.
Responses to this RFI should be submitted electronically to Cynthia.Martin@fda.hhs.gov no later than June 12, 2026 at 10:00AM (ET). Please reference the RFI number in the subject line.
Files
| File | Type | Posted |
|---|---|---|
| RFI_Research Kits.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream) | Food and Drug Administration | Woman-Owned Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity